Trial intelligence / Profile preview

Effect of allopurinol on muscle energetics in older people with impaired physical function

2014-004122-18Phase 4Completed

Sponsor
Tayside Clinical Trials Unit
Start
Oct 2014
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, double-blind trial comparing Allopurinol with Placebo (2 arms). Primary endpoint: Initial rate of phosphocreatine recovery (ViPCr). Started Oct 2014; status: completed.

02

Drugs

allopurinol

Beyond the preview

Go deeper on 2014-004122-18.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2014-004122-18.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call